| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 4e-07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 1e-05 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.4 |